Our conversation addresses the global impact, on both a human and economic scale, of diabetes and obesity, along with the innovations and therapies being developed to combat these diseases. Featured is Nadia Lovell, Senior Equity Strategist Americas, UBS Chief Investment Office. Host: Daniel Cassidy